Scope Fluidics Spolka Akcyjna (FRA:S84) Interest Coverage: 0 (At Loss) (As of Mar. 2026)


FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
44 GF Score
Price €24.00
GF Value €26.71
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Interest Coverage?

Scope Fluidics Spolka Akcyjna FRA:S84 +2.32% 44 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates FRA:S84 with a GF Score™ of 44/100 and a GF Value™ of €26.71. The stock has 4 warning signs investors should review. Among 94 Medical Diagnostics & Research companies, Scope Fluidics Spolka Akcyjna ranks worse than 1063828.72% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Scope Fluidics Spolka Akcyjna's Operating Income for the three months ended in Mar. 2026 was €-3.39 Mil. Scope Fluidics Spolka Akcyjna's Interest Expense for the three months ended in Mar. 2026 was €-0.01 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Interest Coverage or its related term are showing as below:


FRA:S84's Interest Coverage is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 9.155
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Scope Fluidics Spolka Akcyjna  (FRA:S84) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Scope Fluidics Spolka Akcyjna Interest Coverage Related Terms


Scope Fluidics Spolka Akcyjna Interest Coverage Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Scope Fluidics Spolka Akcyjna Interest Coverage Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:S84 vs TMO, DHR, IDXX: Interest Coverage Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Interest Coverage vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Interest Coverage falls into.


FRA:S84
44GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Scope Fluidics Spolka Akcyjna's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Scope Fluidics Spolka Akcyjna's Interest Expense was €-0.05 Mil. Its Operating Income was €-11.01 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.22 Mil.

Scope Fluidics Spolka Akcyjna did not have earnings to cover the interest expense.

Scope Fluidics Spolka Akcyjna's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Scope Fluidics Spolka Akcyjna's Interest Expense was €-0.01 Mil. Its Operating Income was €-3.39 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.17 Mil.

Scope Fluidics Spolka Akcyjna did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #999999 out of 94 companies in the Medical Diagnostics & Research industry.
Is Scope Fluidics Spolka Akcyjna's Interest Coverage too high?
Scope Fluidics Spolka Akcyjna's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #999999 out of 94 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #999999 out of 94 companies for Interest Coverage. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. The industry median Interest Coverage is 9.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.16, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current Interest Coverage of 0 (At Loss). The stock's GF Value™ is €26.71, compared to a current price of €24.00 — trading 10.1% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Scope Fluidics Spolka Akcyjna's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of €24.00 is trading 10.1% below its estimated GF Value™ of €26.71.

Key valuation signals for FRA:S84:

  • Interest Coverage: 0 (At Loss)
  • GF Value™: €26.71 vs. price of €24.00 (10.1% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
44GF Score

Get the complete analysis for FRA:S84

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€24.00
Price
€26.71
GF Value